These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 8356400
1. Specific activation of human peripheral blood gamma/delta + lymphocytes by sonicated antigens of Mycobacterium tuberculosis: role in vitro in killing human bladder carcinoma cell lines. Wang MH, Chen YQ, Gercken J, Ernst M, Böhle A, Flad HD, Ulmer AJ. Scand J Immunol; 1993 Sep; 38(3):239-46. PubMed ID: 8356400 [Abstract] [Full Text] [Related]
2. Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro. Thanhäuser A, Böhle A, Flad HD, Ernst M, Mattern T, Ulmer AJ. Cancer Immunol Immunother; 1993 Jul; 37(2):105-11. PubMed ID: 8319241 [Abstract] [Full Text] [Related]
5. Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro. Liu W, O'Donnell MA, Chen X, Han R, Luo Y. Cancer Immunol Immunother; 2009 Oct; 58(10):1647-55. PubMed ID: 19214503 [Abstract] [Full Text] [Related]
6. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. Hoft DF, Brown RM, Roodman ST. J Immunol; 1998 Jul 15; 161(2):1045-54. PubMed ID: 9670986 [Abstract] [Full Text] [Related]
7. Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells. Luo Y, Yamada H, Evanoff DP, Chen X. Clin Exp Immunol; 2006 Oct 15; 146(1):181-8. PubMed ID: 16968412 [Abstract] [Full Text] [Related]
8. Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon. Böhle A, Thanhäuser A, Ulmer AJ, Ernst M, Flad HD, Jocham D. J Urol; 1993 Dec 15; 150(6):1932-7. PubMed ID: 8230540 [Abstract] [Full Text] [Related]
10. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor. Wang F, Zhang G, Xu T, Ma J, Wang J, Liu S, Tang Y, Jin S, Li J, Xing N. J Exp Clin Cancer Res; 2024 Jan 20; 43(1):24. PubMed ID: 38245792 [Abstract] [Full Text] [Related]
13. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2. Yamada H, Matsumoto S, Matsumoto T, Yamada T, Yamashita U. J Urol; 2000 Aug 20; 164(2):526-31. PubMed ID: 10893638 [Abstract] [Full Text] [Related]
14. Role of the mononuclear phagocyte as an antigen-presenting cell for human gamma delta T cells activated by live Mycobacterium tuberculosis. Boom WH, Chervenak KA, Mincek MA, Ellner JJ. Infect Immun; 1992 Sep 20; 60(9):3480-8. PubMed ID: 1379984 [Abstract] [Full Text] [Related]
16. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells. Brandau S, Suttmann H, Riemensberger J, Seitzer U, Arnold J, Durek C, Jocham D, Flad HD, Böhle A. Clin Cancer Res; 2000 Sep 20; 6(9):3729-38. PubMed ID: 10999767 [Abstract] [Full Text] [Related]
17. The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cells. Thanhäuser A, Böhle A, Schneider B, Reiling N, Mattern T, Ernst M, Flad HD, Ulmer AJ. Cancer Immunol Immunother; 1995 Feb 20; 40(2):103-8. PubMed ID: 7882379 [Abstract] [Full Text] [Related]
18. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin. Esin S, Batoni G, Pardini M, Favilli F, Bottai D, Maisetta G, Florio W, Vanacore R, Wigzell H, Campa M. Immunology; 2004 May 20; 112(1):143-52. PubMed ID: 15096193 [Abstract] [Full Text] [Related]
19. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis. Al-Attiyah R, Mustafa AS, Abal AT, El-Shamy AS, Dalemans W, Skeiky YA. Clin Exp Immunol; 2004 Oct 20; 138(1):139-44. PubMed ID: 15373916 [Abstract] [Full Text] [Related]